Insulin and insulin-like growth factor I differentially induce α1- adrenergic receptor subtype expression in rat vascular smooth muscle cells

Journal of Clinical Investigation

Volumn 98, Issue 8, 1996, Pages 1826-1834

  Hu, Zhuo Wei ^a,b   Shi, Xiao You ^a   Hoffman, Brian B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

atherosclerosis; gene expression; hyperinsulinemia; vascular biology

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; INSULIN; NORADRENALIN; PRAZOSIN; PROTEIN KINASE C INHIBITOR; RECEPTOR SUBTYPE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; CORONARY RISK; HYPERINSULINEMIA; HYPERTENSION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER;

EID: 0029981167     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118983     Document Type: Article

References (44)

1. Meehan, W.P., C.H. Darwin, N.B. Maalouf, T.A. Buchanan, and M.F. Saad. 1993. Insulin and hypertension: are they related? Steroids. 58:621-634.
2. Standley, P., M. Bakir, and J.R. Sowers. 1993. Vascular insulin abnormalities, hypertension, and accelerated atherosclerosis. Am. J. Kid. Dis. 21 (Suppl. 3):39-46.
3. Reaven, G.M. 1995. Pathophysiology of insulin resistance in human disease. Physiol. Rev. 75:473-486.
4. Weidmann, P., L. Bohlen, and M. de Courten. 1995. Insulin resistance and hyperinsulinemia in hypertension. J. Hypertension. 13 (Suppl.):S65-S72.
5. Zemel, M.B., J.H. Kim, R.P. Woychik, E.J. Michaud, S.H. Kadwell, I.R. Patel, and W.O. Wilkison. 1995. Agouti regulation of intracellular calcium: role in the insulin resistance of viable yellow mice. Proc. Natl. Acad. Sci. USA. 92: 4733-4737.
6. Hall, J.E., M.W. Brands, D.H. Zappe, and M.A. Galicia. 1995. Insulin resistance, hyperinsulinemia, and hypertension: causes, consequences, or merely correlations? Proc. Soc. Exp. Biol. Med. 208:317-329.
7. Frank, H.J.L., E.R. Levin, R.M. Hu, and A. Pedram. 1993. Insulin stimulates endothelin blinding and action on the cultured vascular smooth muscle cells. Endocrinology. 133:1092-1097.
8. Townsend, R.R., R. Yamamoto, M. Nickols, D.J. DiPette, and G.A. Nickols. 1992. Insulin enhances pressor responses to norepinephrine in rat mesenteric vasculature. Hypertension (Dallas). 19(2 Suppl.):II105-110.
9. Sachinidis, Y.K.A., A.J. Wieczorek, A.R. Dusing, and H. Vetter. 1993. Insulin enhances angiotensin II induced DNA synthesis in vascular smooth muscle cells of the rat. Clin. Investig. 71:379-382.
10. Vargas, H.M., and A.J. Gorman. 1995. Vascular aradrenergic receptor subtypes in the regulation of arterial pressure. Life Sci. 57:2291-2308.
11. Bylund, D.B., J.W. Regan, J.E. Faber, J.P. Hieble, C.R. Triggle, and R.R. Ruffolo, Jr. 1995. Vascular α-adrenoceptors: from the gene to the human. Can. J. Physiol. Pharmacol. 73:533-543.
12. 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy. Proc. Natl. Acad. Sci. USA. 91:10109-10113.
13. 1-adrenergic induction of the skeletal α-actin promoter during cardiac myocyte hypertrophy. Transcriptional enhancer factor-1 and protein kinase C as conserved transducers of the fetal program in cardiac growth. J. Biol. Chem. 270:410-417.
14. 1-adrenergic receptor-induced c-fos gene expression in rat aorta and cultured vascular smooth muscle cells. J. Clin. Invest. 94:210-218.
15. Hu, Z.W., X.Y. Shi, M. Okazaki, and B.B. Hoffman. 1995. Angiotensin II induces transcription and expression of α1-adrenergic receptors in vascular smooth muscle cells. Am. J. Physiol. 268:H1006-H1014.
16. Thorburn, J., J.A. Frost, and A. Thorburn. 1994. Mitogen-activated protein kinases mediate changes in gene expression, but not cyctoskeletal organization associated with cardiac muscle cell hypertrophy. J. Cell. Biol. 126:1565-1572.
17. Thorburn, J., and A. Thorburn. 1994. The tyrosine kinase inhibitor, genistein, prevents alpha-adrenergic-induced cardiac muscle cell hypertrophy by inhibiting activation of the Ras-MAP kinase signaling pathway. Biochem. Biophys. Res. Commun. 202:1586-1591.
18. 1-adrenergic receptors activate phosphatidylinositol 3-kinase in human vascular smooth muscle cells: role in mitogenesis. J. Biol. Chem. 271:8977-8982.
19. Landsberg, L. 1994. Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system. J. Cardivasc. Pharmacol. 23 (Suppl. 1):S1-S8.
20. Hsueh, W.A., and T.A. Buchanan. 1994. Obesity and hypertension. Endocrinol. Metab. Clin. North. Am. 23:405-427.
21. 1B-adrenergic receptor gene in DDT1 MF-2 cells. J. Biol. Chem. 268:3390-3395.
22. Greenberg, S.M., E.H. Koo, D.J. Selkoe, W.Q. Qiu, and K.S. Kosik. 1994. Secreted β-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances τ phosphorylation. Proc. Natl. Acad. Sci. USA 91: 7104-7108.
23. Hieble, J.P., D.B. Bylund, D.E. Clarke, D.C. Eikenburg, S.Z. Langer, R.J. Lefkowitz, K.P. Minneman, and R.R. Ruffolo, Jr. 1995. International union of pharmacology. X. recommendation for nomenclature of α-adrenoceptors: consensus update. Pharmacol. Rev. 47:267-270.
24. Jhun, B.H., D.W. Rose, B.L. Seely, L. Rameh, L. Cantley, A.R. Saltiel, and J.M. Olefsky. 1994. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol. Cell Biol. 14:7466-7475.
25. Laws, A., and G.M. Reaven. 1993. Insulin resistance and risk factors for coronary heart disease. Bail. Clin. Endocrinol. Metab. 7:1063-1078.
26. Reaven, G.M., and B.B. Hoffman. 1987. A role for insulin in the aetiology and course of hypertension? Lancet. ii:435-437.
27. Ferrannini, E. 1995. Physiological and metabolic consequences of obesity. Metab. Clin. Exp. 44(Suppl. 3):15-17.
28. 1-Adrenoceptor blockade reduces the angiotensin II-induced vascular smooth muscle cell DNA synthesis in the rat thoracic aorta and carotid artery. Circ. Res. 70:1122-1127.
29. Perondi, R., A. Saino, R.A. Tio, G. Pomidossi, L. Gregorini, P. Alessio, A. Morganti, A. Zanchetti, and G. Mancia. 1992. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease. Circulation. 85:2004-2013.
30. Blaes, N., and J.P. Boissel. 1983. Growth-stimulating effect of catecholamines on rat aortic smooth muscle cells in culture. J. Cell Physiol. 116:167-172.
31. Bell, L., and J.A. Madri. 1989. Effect of platelet factors on migration of cultured bovine aortic endothelial and smooth muscle cells. Circ. Res. 65:1057-1065.
32. 2-adrenergic inhibition of DNA synthesis in vascular smooth muscle cells. Mol. Pharmacol. 37:30-36.
33. 1-Adrenergic stimulation of platelet-derived growth factor A-chain gene expression in rat aorta. J. Biol. Chem. 265:1082-1088.
34. Devedjian, J.C., M. Fargues, C. Denis-Pouxviel, D. Daviaud, H. Prats, and H. Paris. 1991. Regulation of the alpha 2-adrenergic receptor in the HT29 cell line. Effects of insulin and growth factors. J. Biol. Chem. 266:14359-14366.
35. Haddcock, J.R., J.D. Port, M.S. Gelman, and C.C. Malbon. 1992. Crosstalk between tyrosine kinase and G-protein-linked receptors. Phosphorylation of beta 2-adrenergic receptors in response to insulin. J. Biol. Chem. 267:26017-26022.
36. Exton, J.H. 1991. Some thoughts on the mechanism of action of insulin. Diabetes. 40:521-526.
37. 1B-adrenergic receptor. J. Biol. Chem. 267:21936-21945.
38. 1B adrenergic gene in liver is controlled by three distinct promoters. J. Biol. Chem. 269:15762-15767.
39. 1B adrenergic gene middle promoter contains multiple binding sites for sequence-specific proteins including a novel ubiquitous transcription factor. J. Biol. Chem. 270:5614-5619.
40. Standley, P.R., and K.A. Rose. 1994. Insulin and insulin-like growth factor-1 modulation of glucose transport in arterial smooth muscle cells: implication of GLUT-4 in the vasculature. Am. J. Hypertens. 7:357-362.
41. Bornfeldt, K.E., R.A. Gidlof, A. Wasteson, A. Lake, A. Skottner, and H.J. Arnqvist. 1991. Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities. Diabetologia. 34:307-313.
42. Lee, P.K., R.L. Hintz, R.G. Rosenfeld, and W.E. Benitz. 1988. Presence of insulin-like growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells. In Vitro Cell Dev. Biol. 24:921-926.
43. Arnqvist, H.J., K.E. Bornfeldt, Y. Chen, and T. Lindstrom. 1995. The insulin-like growth factor system in vascular smooth muscle: interaction with insulin and growth factors. Metab. Clin. Exp. 44 (10 Suppl.) 4:58-66.
44. Banskota, N.K., R. Taub, K. Zellner, P. Olsen, and G.L. King. 1989. Characterization of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-I. Diabetes. 38:123-129.